Acrodermatitis chronica atrophicans epidemiology and demographics

Acrodermatitis chronica atrophicans Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Acrodermatitis chronica atrophicans from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Acrodermatitis chronica atrophicans epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Acrodermatitis chronica atrophicans epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Acrodermatitis chronica atrophicans epidemiology and demographics
CDC on Acrodermatitis chronica atrophicans epidemiology and demographics
Acrodermatitis chronica atrophicans epidemiology and demographics in the news
Blogs on Acrodermatitis chronica atrophicans epidemiology and demographics
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Acrodermatitis chronica atrophicans epidemiology and demographics

Xyz Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Xyz from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Interventions
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Acrodermatitis chronica atrophicans epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Acrodermatitis chronica atrophicans epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Acrodermatitis chronica atrophicans epidemiology and demographics
CDC on Acrodermatitis chronica atrophicans epidemiology and demographics
Acrodermatitis chronica atrophicans epidemiology and demographics in the news
Blogs on Acrodermatitis chronica atrophicans epidemiology and demographics
Directions to Hospitals Treating Psoriasis
Risk calculators and risk factors for Acrodermatitis chronica atrophicans epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anahita Deylamsalehi, M.D.[2]

Epidemiology and Demographics

Incidence

• The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.

Prevalence

• The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
• The prevalence of [disease/malignancy] is estimated to be [number] cases annually.

Case-fatality rate/Mortality rate

• The case-fatality rate/mortality rate of [disease name] is approximately [number range].

Age

• Patients of all age groups may develop [disease name].
• The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.

Race

• [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].

Gender

• [Disease name] affects men and women equally.

Region

• The majority of acrodermatitis chronica atrophicans cases are reported in northern, central and eastern Europe.
• Lately few cases of acrodermatitis chronica atrophicans have been reported in the United States which were associated to Lyme disease (besides European immigrants).